|4Aug 11, 6:33 PM ET

Fore Henrietta 4

4 · Theravance Biopharma, Inc. · Filed Aug 11, 2017

Insider Transaction Report

Form 4
Period: 2017-08-11
Transactions
  • Purchase

    Ordinary Shares

    2017-08-11$23.99/sh+6,000$143,93224,000 total
Footnotes (1)
  • [F1]Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $23.98 to $23.989 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -